MediZine taps AOL Health head, launches vertical content offering

Consumer health education company MediZine is launching a new point-of-care product for the offices of specialist physicians and has hired Carla Wojnaroski, the former head of AOL Health & Living, to direct content for all its new and existing offerings. The new product, MDminute, will offer 10 condition-specific vertical health titles to be distributed quarterly in specialist doctors offices. The Diabetes edition will roll out this month, followed by Heart Health and General Health in August. The remaining editions—including Allergies/Asthma, Dermatology, Digestion/Diet, Cancer, Arthritis and Mental Health—will launch by the end of the year. All publications will encourage patients to view content online and to sign up for individually-tailored email updates. As executive VP, content and new media, Wojnaroski will head up and develop content on all offerings across all channels. MediZine’s existing products include the point-of-care publications Remedy, Healthy Living and Diabetes Focus—along with their integrated online components—and also the TV broadcast segments, Daily Health Updates. Wojnaroski previously spent seven years at AOL culminating in the role of VP, general manager for its Health & Living division.
You must be a registered member of MMM to post a comment.

Email Newsletters

What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.